Cited by 720Cardiomyopathy and Myosin StudiesViral Infections and Immunology ResearchCardiovascular Effects of Exercise

The DOI matches its Crossref record; 235 of the 235 references it cites were found in a registry or an index.

Dilated cardiomyopathy

Open access

Schultheiss, Heinz-Peter, Fairweather, DeLisa, Caforio, Alida L. P., Escher, Felicitas, Hershberger, Ray E., Lipshultz, Steven E., Liu, Peter P., Matsumori, Akira, Mazzanti, Andrea, McMurray, John, Priori, Silvia G.·2019·Nature Reviews Disease Primers

DOI 10.1038/s41572-019-0084-1PMC PMC7096917

Open this paper in CoChat — free account Open PDF

Abstract

Dilated cardiomyopathy (DCM) is a clinical diagnosis characterized by left ventricular or biventricular dilation and impaired contraction that is not explained by abnormal loading conditions (for example, hypertension and valvular heart disease) or coronary artery disease. Mutations in several genes can cause DCM, including genes encoding structural components of the sarcomere and desmosome. Nongenetic forms of DCM can result from different aetiologies, including inflammation of the myocardium due to an infection (mostly viral); exposure to drugs, toxins or allergens; and systemic endocrine or autoimmune diseases. The heterogeneous aetiology and clinical presentation of DCM make a correct and timely diagnosis challenging. Echocardiography and other imaging techniques are required to assess ventricular dysfunction and adverse myocardial remodelling, and immunological and histological analyses of an endomyocardial biopsy sample are indicated when inflammation or infection is suspected. As DCM eventually leads to impaired contractility, standard approaches to prevent or treat heart failure are the first-line treatment for patients with DCM. Cardiac resynchronization therapy and implantable cardioverter-defibrillators may be required to prevent life-threatening arrhythmias. In addition, identifying the probable cause of DCM helps tailor specific therapies to improve prognosis. An improved aetiology-driven personalized approach to clinical care will benefit patients with DCM, as will new diagnostic tools, such as serum biomarkers, that enable early diagnosis and treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41572-019-0084-1

Cites

235 of 235 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Self-citation
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
Vos, T., Allen, C., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31678-6 · Cited by 7,253
Angiotensin-neprilysin inhibition versus enalapril in heart failure
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957
Self-citation
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
Cleland, J. G. F., Daubert, J., Erdmann, E., Freemantle, N., Gras, D., KAPPENBERGER, L. J., & Tavazzi, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050496 · Cited by 6,300
Cardiac Resynchronization in Chronic Heart Failure
Abraham, W. T., Fisher, W. G., Smith, A. L., Delurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Packer, M., Clavell, A. L., Hayes, D. L., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013168 · Cited by 4,648
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
Self-citation
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
Caforio, A. L. P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., Fu, M., Heliö, T., Heymans, S., Jahns, R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht210 · Cited by 3,479
Self-citation
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies
(1996) · Circulation · doi:10.1161/01.cir.93.5.841 · Cited by 3,458
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., Estes, N. A. M., Foster, E., Greenberg, H., Higgins, S. L., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906431 · Cited by 3,157
Eplerenone in patients with systolic heart failure and mild symptoms
Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111
Self-citation
The effect of digoxin on mortality and morbidity in patients with heart failure
(1997) · New England Journal of Medicine · doi:10.1056/nejm199702203360801 · Cited by 3,016
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
Elliot, P. M., Andersson, B., Arbustini, E., Bilińska, Z. T., Cecchi, F., Charron, P., Dubourg, O., Kühl, U., Maisch, B., McKenna, W. J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm342 · Cited by 2,995
ClinVar: public archive of interpretations of clinically relevant variants
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Hoover, J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1222 · Cited by 2,758
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
McMurray, J. J., Östergren, J., Swedberg, K., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer, M. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14283-3 · Cited by 2,604
Self-citation
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Swedberg, K., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61198-1 · Cited by 2,563
Untitled work
O'Connor (2009) · doi:10.1001/jama.2009.454 · Cited by 2,173
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Zhang, S., Liu, X., Bawa‐Khalfe, T., Lu, L., Lyu, Y. L., Liu, L. F., & Yeh, E. T. H. (2012) · Nature Medicine · doi:10.1038/nm.2919 · Cited by 2,007
Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure
Garg, R. (1995) · JAMA · doi:10.1001/jama.273.18.1450 · Cited by 1,993
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
Self-citation
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure
Tang, A. S. L., Wells, G. A., Talajic, M., Arnold, M. O., Sheldon, R., Connolly, S., Hohnloser, S. H., Nichol, G., Birnie, D. H., Sapp, J. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1009540 · Cited by 1,859
Defibrillator implantation in patients with nonischemic systolic heart failure
Køber, L., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L., Korup, E., Jensen, G., Hildebrandt, P., Steffensen, F. H., Bruun, N. E., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1608029 · Cited by 1,763
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial
Granger, C. B., McMurray, J. J., Yusuf, S., Held, P., Michelson, E. L., Olofsson, B., Östergren, J., Pfeffer, M. A., & Swedberg, K. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14284-5 · Cited by 1,686
Self-citation
ClinGen — The Clinical Genome Resource
Rehm, H. L., Berg, J. S., Brooks, L. D., Bustamante, C. D., Evans, J. P., Landrum, M. J., Ledbetter, D. H., Maglott, D. R., Martin, C. L., Nussbaum, R. L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1406261 · Cited by 1,496
Truncations of titin causing dilated cardiomyopathy
Herman, D. S., Lam, L., Taylor, M. R. G., Wang, L., Teekakirikul, P., Christodoulou, D., Conner, L., DePalma, S. R., McDonough, B., Sparks, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110186 · Cited by 1,485
Missense Mutations in the Rod Domain of the Lamin A/C Gene as Causes of Dilated Cardiomyopathy and Conduction-System Disease
Fatkin, D., MacRae, C. A., Sasaki, T., Wolff, M. R., Porcu, M., Frenneaux, M. P., Atherton, J. J., Vidaillet, H. J., Jr., Spudich, S., Girolami, U. D., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912023412302 · Cited by 1,366
Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases
Pinto, Y. M., Elliot, P. M., Arbustini, E., Adler, Y., Anastasakis, A., Böhm, M., Duboc, D., Gimeno, J. R., de Groote, P., Imazio, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv727 · Cited by 1,122
Self-citation
Towards precision medicine
Ashley, E. A. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.86 · Cited by 1,116
Doxorubicin Cardiomyopathy
Chatterjee, K., Zhang, J., Honbo, N. Y., & Karliner, J. S. (2009) · Cardiology · doi:10.1159/000265166 · Cited by 1,074
Incidence, Causes, and Outcomes of Dilated Cardiomyopathy in Children
Towbin, J. A., Lowe, A. M., Colan, S. D., Sleeper, L. A., Orav, E. J., Clunie, S. K., Messere, J. E., Cox, G. F., Lurie, P. R., Hsu, D. T., et al. (2006) · JAMA · doi:10.1001/jama.296.15.1867 · Cited by 1,055
Self-citation
Dilated cardiomyopathy: the complexity of a diverse genetic architecture
Hershberger, R. E., Hedges, D. J., & Morales, A. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.105 · Cited by 1,036
Self-citation
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
Cardinale, D. M., Colombo, A., Sandri, M. T., Lamantia, G., Colombo, N., Civelli, M., Martinelli, G., Veglia, F., Fiorentini, C., & Cipolla, C. M. (2006) · Circulation · doi:10.1161/circulationaha.106.635144 · Cited by 1,020
Idiopathic Dilated Cardiomyopathy
Dec, G. W., & Fuster, V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412083312307 · Cited by 957
The Incidence of Pediatric Cardiomyopathy in Two Regions of the United States
Lipshultz, S. E., Sleeper, L. A., Towbin, J. A., Lowe, A. M., Orav, E. J., Cox, G. F., Lurie, P. R., McCoy, K., McDonald, M. A., Messere, J. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021715 · Cited by 889
Self-citation
The Epidemiology of Childhood Cardiomyopathy in Australia
Nugent, A. W., Daubeney, P. E. F., Chondros, P., Carlin, J. B., Cheung, M. M. H., Wilkinson, L. C., Davis, A. M., Kahler, S. G., Chow, C. W., Wilkinson, J. L., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021737 · Cited by 782
Mechanistic Pathways of Sex Differences in Cardiovascular Disease
Regitz‐Zagrosek, V., & Kararigas, G. (2016) · Physiological Reviews · doi:10.1152/physrev.00021.2015 · Cited by 758
Myocarditis
Sagar, S., Liu, P. P., & Cooper, L. T. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60648-x · Cited by 743
Self-citation
Chronic Progressive Cardiac Dysfunction Years After Doxorubicin Therapy for Childhood Acute Lymphoblastic Leukemia
Lipshultz, S. E., Lipsitz, S. R., Sallan, S. E., Dalton, V., Mone, S. M., Gelber, R. D., & Colan, S. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.121 · Cited by 727
Self-citation
Mutations in Sarcomere Protein Genes as a Cause of Dilated Cardiomyopathy
Kamisago, M., Sharma, S. D., DePalma, S. R., Solomon, S., Sharma, P., McDonough, B., Smoot, L., Mullen, M. P., Woolf, P. K., Wigle, E. D., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432304 · Cited by 720
Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice
Okazaki, T., Tanaka, Y., Nishio, R., Mitsuiye, T., Mizoguchi, A., Wang, J., Ishida, M., Hiai, H., Matsumori, A., Minato, N., et al. (2003) · Nature Medicine · doi:10.1038/nm955 · Cited by 689
Self-citation
Expression and Regulation of ST2, an Interleukin-1 Receptor Family Member, in Cardiomyocytes and Myocardial Infarction
Weinberg, E. O., Shimpo, M., Keulenaer, G. W. D., MacGillivray, C., Tominaga, S., Solomon, S. D., Rouleau, J. L., & Lee, R. T. (2002) · Circulation · doi:10.1161/01.cir.0000038705.69871.d9 · Cited by 677
Predictors of Outcome in Patients With Suspected Myocarditis
Kindermann, I., Kindermann, M., Kandolf, R., Klingel, K., Bültmann, B. D., Müller, T. M., Lindinger, A., & Böhm, M. (2008) · Circulation · doi:10.1161/circulationaha.108.769489 · Cited by 676
Role of innate and adaptive immune mechanisms in cardiac injury and repair
Epelman, S., Liu, P. P., & Mann, D. L. (2015) · Nature reviews. Immunology · doi:10.1038/nri3800 · Cited by 663
Self-citation
Viral myocarditis—diagnosis, treatment options, and current controversies
Pollack, A., Kontorovich, A. R., Fuster, V., & Dec, G. W. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.108 · Cited by 657
Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]
Cleland, J. G. F., Daubert, J., Erdmann, E., Freemantle, N., Gras, D., KAPPENBERGER, L. J., Tavazzi, L., & on behalf of The CARE-HF Study Investigators (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl099 · Cited by 656
Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984.
Codd, M., SUGRUE, D. D., Gersh, B. J., & Melton, L. J. (1989) · Circulation · doi:10.1161/01.cir.80.3.564 · Cited by 638
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies
Ware, J. S., Li, J., Mazaika, E., Yasso, C. M., DeSouza, T., Cappola, T. P., Tsai, E. J., Hilfiker‐Kleiner, D., Kamiya, C., Mazzarotto, F., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505517 · Cited by 625
Self-citation
Dilated Cardiomyopathy and Heart Failure Caused by a Mutation in Phospholamban
Schmitt, J. P., Kamisago, M., Asahi, M., Li, G. H., Ahmad, F., Mende, U., Kranias, E. G., MacLennan, D. H., Seidman, J. G., & Seidman, C. E. (2003) · Science · doi:10.1126/science.1081578 · Cited by 619
Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy
Gerull, B., Gramlich, M., Atherton, J. J., McNabb, M., Trombitás, K., Klaassen, S., Seidman, J. G., Seidman, C. E., Granzier, H., Labeit, S., et al. (2002) · Nature Genetics · doi:10.1038/ng815 · Cited by 616
Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study
Frustaci, A., Russo, M. A., & Chimenti, C. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp249 · Cited by 604
Evaluating the Clinical Validity of Gene-Disease Associations: An Evidence-Based Framework Developed by the Clinical Genome Resource
Strande, N. T., Riggs, E. R., Buchanan, A. H., Ceyhan‐Birsoy, O., DiStefano, M. T., Dwight, S. S., Goldstein, J., Ghosh, R., Seifert, B. A., Sneddon, T. P., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.04.015 · Cited by 602
Viral Persistence in the Myocardium Is Associated With Progressive Cardiac Dysfunction
Kühl, U., Pauschinger, M., Seeberg, B., Laßner, D., Noutsias, M., Poller, W. C., & Schultheiß, H. (2005) · Circulation · doi:10.1161/circulationaha.105.548156 · Cited by 599
CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling
Irie-Sasaki, J., Sasaki, T., Matsumoto, W., Opavsky, A., Cheng, M., Welstead, G. G., Griffiths, E. K., Krawczyk, C. M., Richardson, C. D., AITKEN, K. J., et al. (2001) · Nature · doi:10.1038/35053086 · Cited by 572
Self-citation
The Diagnosis and Evaluation of Dilated Cardiomyopathy
Japp, A. G., Gulati, A., Cook, S. A., Cowie, M., & Prasad, S. K. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.590 · Cited by 568
Sodium Channel Mutations and Susceptibility to Heart Failure and Atrial Fibrillation
Olson, T. M. (2005) · JAMA · doi:10.1001/jama.293.4.447 · Cited by 552
Drug-induced mitochondrial dysfunction and cardiotoxicity
Varga, Z. V., Ferdinandy, P., Liaudet, L., & Pacher, P. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00554.2015 · Cited by 547
Cardiac myosin induces myocarditis in genetically predisposed mice.
Neu, N., Rose, N. R., Beisel, K. W., Herskowitz, A., Gurri-Glass, G., & Craig, S. W. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.11.3630 · Cited by 523
Classification, Epidemiology, and Global Burden of Cardiomyopathies
McKenna, W. J., Maron, B. J., & Thiene, G. (2017) · Circulation Research · doi:10.1161/circresaha.117.309711 · Cited by 510
Identification of Serum Soluble ST2 Receptor as a Novel Heart Failure Biomarker
Weinberg, E. O., Shimpo, M., Hurwitz, S., Tominaga, S., Rouleau, J. L., & Lee, R. T. (2003) · Circulation · doi:10.1161/01.cir.0000047274.66749.fe · Cited by 506
Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease
Roberts, A. M., Ware, J. S., Herman, D. S., Schäfer, S., Baksi, J. A., Bick, A. G., Buchan, R. J., Walsh, R., John, S., Wilkinson, S., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010134 · Cited by 502
Interferon-β Treatment Eliminates Cardiotropic Viruses and Improves Left Ventricular Function in Patients With Myocardial Persistence of Viral Genomes and Left Ventricular Dysfunction
Kühl, U., Pauschinger, M., Schwimmbeck, P. L., Seeberg, B., Lober, C., Noutsias, M., Poller, W. C., & Schultheiß, H. (2003) · Circulation · doi:10.1161/01.cir.0000072766.67150.51 · Cited by 499
Natural history of dilated cardiomyopathy due to lamin A/C gene mutations
Taylor, M. R., Fain, P. R., Sinagra, G., Robinson, M. L., Robertson, A. D., Carniel, E., Lenarda, A. D., Bohlmeyer, T. J., Ferguson, D. A., Brodsky, G. L., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02954-6 · Cited by 488
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies
Ortiz-Genga, M., Cuenca, S., Ferro, M. D., Zorio, E., Salgado‐Aranda, R., Climent, V. E., Padrón-Barthe, L., Duro-Aguado, I., Jiménez‐Jáimez, J., Hidalgo-Olivares, V. M., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.927 · Cited by 488
A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis
Caforio, A. L. P., Calabrese, F., Angelini, A., Tona, F., Vinci, A., Bottaro, S., Ramondo, A. B., Carturan, E., Iliceto, S., Thiene, G., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm076 · Cited by 487
Self-citation
Genetic mutations and mechanisms in dilated cardiomyopathy
McNally, E. M., Golbus, J. R., & Puckelwartz, M. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62862 · Cited by 482
Clinical and genetic issues in familial dilated cardiomyopathy
Burkett, E., & Hershberger, R. E. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.066 · Cited by 467
Self-citation
Immunosuppressive Therapy for Active Lymphocytic Myocarditis: Virological and Immunologic Profile of Responders Versus Nonresponders
Frustaci, A., Chimenti, C., Calabrese, F., Pieroni, M., Thiene, G., & Maseri, A. (2003) · Circulation · doi:10.1161/01.cir.0000048147.15962.31 · Cited by 462
SCN5A Mutation Associated With Dilated Cardiomyopathy, Conduction Disorder, and Arrhythmia
McNair, W. P., Ku, L., Taylor, M. R. G., Fain, P. R., Dao, D., Wolfel, E. E., & Mestroni, L. (2004) · Circulation · doi:10.1161/01.cir.0000144458.58660.bb · Cited by 450
Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases
Rapezzi, C., Arbustini, E., Caforio, A. L. P., Charron, P., Gimeno, J. R., Heliö, T. M., Linhart, A., Mogensen, J., Pinto, Y. M., Ristić, A. D., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs397 · Cited by 441
Self-citation
Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes
Ingles, J., Goldstein, J., Thaxton, C., Caleshu, C. A., Corty, E. W., Crowley, S. B., Dougherty, K. E., Harrison, S. M., McGlaughon, J., Milko, L. V., et al. (2019) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.119.002460 · Cited by 434
Self-citation
Implantable Defibrillators for the Prevention of Mortality in Patients With Nonischemic Cardiomyopathy
Desai, A. S., Fang, J. C., Maisel, W. H., & Baughman, K. L. (2004) · JAMA · doi:10.1001/jama.292.23.2874 · Cited by 403
Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart Failure
Rehman, S., Mueller, T., & Januzzi, J. L. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.042 · Cited by 385
Direct evidence for a β1-adrenergic receptor–directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy
Jahns, R., Boivin, V., Hein, L., Triebel, S., Angermann, C. E., Ertl, G., & Lohse, M. J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20149 · Cited by 384
Gender differences in the cardiovascular effect of sex hormones
Vitale, C., Mendelsohn, M. E., & Rosano, G. M. C. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.105 · Cited by 375
Racial Differences in the Outcome of Left Ventricular Dysfunction
Dries, D. L., Exner, D. V., Gersh, B. J., Cooper, H. A., Carson, P. E., & DOMANSKI, M. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902253400804 · Cited by 368
Genome-wide Studies of Copy Number Variation and Exome Sequencing Identify Rare Variants in BAG3 as a Cause of Dilated Cardiomyopathy
Norton, N., Li, D., Rieder, M. J., Siegfried, J. D., Rampersaud, E., Zuchner, S. L., Mangos, S., Gonzalez‐Quintana, J., Wang, L., McGee, S. R., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.01.016 · Cited by 366
Self-citation
Mutations in Ribonucleic Acid Binding Protein Gene Cause Familial Dilated Cardiomyopathy
Brauch, K. M., Karst, M. L., Herron, K. J., de Andrade, M., Pellikka, P. A., Rodeheffer, R. J., Michels, V. V., & Olson, T. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.038 · Cited by 364
Titin-truncating variants affect heart function in disease cohorts and the general population
Schäfer, S., de Marvao, A., Adami, E., Fiedler, L. R., Ng, B., Khin, E. S. W., Rackham, O. J. L., van Heesch, S., Pua, C. J., Kui, M., et al. (2016) · Nature Genetics · doi:10.1038/ng.3719 · Cited by 360
Myosin-induced acute myocarditis is a T cell-mediated disease.
Smith, S. C., & Allen, P. (1991) · Journal of Immunology · doi:10.4049/jimmunol.147.7.2141 · Cited by 360
Rising mortality associated with hepatitis C virus in the United States, 2003–2013
Ly, K. N., Hughes, E. M., Jiles, R. B., & Holmberg, S. D. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw111 · Cited by 358
Interleukin-17A Is Dispensable for Myocarditis but Essential for the Progression to Dilated Cardiomyopathy
Baldeviano, G. C., Barin, J. G., Talor, M. V., Srinivasan, S., Bedja, D., Zheng, D., Gabrielson, K., Iwakura, Y., Rose, N. R., & Cihakova, D. (2010) · Circulation Research · doi:10.1161/circresaha.109.213157 · Cited by 334
Sex and Gender Differences in Myocarditis and Dilated Cardiomyopathy
Fairweather, D., Cooper, L. T., & Blauwet, L. A. (2013) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2012.07.003 · Cited by 325
Self-citation
Inflammation as a Therapeutic Target in Heart Failure? A Scientific Statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology
Heymans, S. R. B., Hirsch, E., Anker, S. D., Aukrust, P., Balligand, J., Tervaert, J. W. C., Drexler, H., Filippatos, G. S., Felix, S. B., Gullestad, L. L., et al. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfn043 · Cited by 325
Self-citation
Alcoholic Cardiomyopathy
Piano, M. R. (2002) · CHEST Journal · doi:10.1378/chest.121.5.1638 · Cited by 322
Update 2011: Clinical and Genetic Issues in Familial Dilated Cardiomyopathy
Hershberger, R. E., & Siegfried, J. D. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.015 · Cited by 322
Self-citation
Genetic Etiology for Alcohol-Induced Cardiac Toxicity
Ware, J. S., Amor‐Salamanca, A., Tayal, U., Govind, R., Serrano, I., Salazar‐Mendiguchía, J., García‐Pinilla, J. M., Pascual-Figal, D. A., Núñez, J. E., Guzzo-Merello, G., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.462 · Cited by 321
Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy.
Caforio, A. L., Grazzini, M., Mann, J. M., Keeling, P. J., Bottazzo, G. F., McKenna, W. J., & Schiaffino, S. (1992) · Circulation · doi:10.1161/01.cir.85.5.1734 · Cited by 315
Self-citation
Cardiovascular effects of cocaine: An autopsy study of 40 patients
Virmani, R., Robinowitz, M., Smialek, J. E., & Smyth, D. F. (1988) · American Heart Journal · doi:10.1016/0002-8703(88)90078-6 · Cited by 315
Detection of Adenoviral Genome in the Myocardium of Adult Patients With Idiopathic Left Ventricular Dysfunction
Pauschinger, M., Bowles, N. E., Fuentes-Garcia, F. J., Pham, V., Kühl, U., Schwimmbeck, P. L., Schultheiß, H., & Towbin, J. A. (1999) · Circulation · doi:10.1161/01.cir.99.10.1348 · Cited by 315
The management of myocarditis
Schultheiß, H., Kühl, U., & Cooper, L. T. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr165 · Cited by 306
Clinical and genetic issues in dilated cardiomyopathy: A review for genetics professionals
Hershberger, R. E., Morales, A., & Siegfried, J. D. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181f2481f · Cited by 289
Self-citation
Inflammation in Myocardial Diseases
Marchant, D., Boyd, J. H., Lin, D. C., Granville, D. J., Garmaroudi, F. S., & McManus, B. M. (2012) · Circulation Research · doi:10.1161/circresaha.111.243170 · Cited by 289
Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy
Felix, S. B., Staudt, A., Dörffel, W. V., Stangl, V., Merkel, K., Pohl, M., Döcke, W. D., Morgera, S., Neumayer, H. H., Wernecke, K. D., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00568-4 · Cited by 284
Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients
Hsu, Y., Lin, J., Ho, H. J., Kao, Y.-H., Huang, Y., Hsiao, N., Wu, M., Liu, Y.-Y., & Wu, C. (2013) · Hepatology · doi:10.1002/hep.26892 · Cited by 275
REVEAL: a contemporary US pulmonary arterial hypertension registry
McGoon, M. D., & Miller, D. P. (2012) · European Respiratory Review · doi:10.1183/09059180.00008211 · Cited by 272
Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease
Caforio, A. L. P., Adler, Y., Agostini, C., Allanore, Y., Anastasakis, A., Arad, M., Böhm, M., Charron, P., Elliot, P. M., Eriksson, U., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx321 · Cited by 264
Self-citation
Epidemiology of Idiopathic Cardiomyopathies in Children and Adolescents: A Nationwide Study in Finland
Arola, A. M., Jokinen, E. V., Ruuskanen, O., Saraste, M., Pesonen, E. J., Kuusela, A. L., Tikanoja, T., Paavilainen, T., & Simell, O. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009291 · Cited by 263
Mutations that Alter the Surface Charge of Alpha-tropomyosin are Associated with Dilated Cardiomyopathy
Olson, T. M., Kishimoto, N. Y., Whitby, F. G., & Michels, V. V. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1339 · Cited by 262
The MOGE(S) Classification for a Phenotype–Genotype Nomenclature of Cardiomyopathy
Arbustini, E., Narula, N., Dec, G. W., Reddy, K. S., Greenberg, B., Kushwaha, S. S., Marwick, T. H., Pinney, S., Bellazzi, R., Favalli, V., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.1644 · Cited by 260
High Prevalence of Cardiac Parvovirus B19 Infection in Patients With Isolated Left Ventricular Diastolic Dysfunction
Tschöpe, C., Bock, C. –., Kasner, M., Noutsias, M., Westermann, D., Schwimmbeck, P. L., Pauschinger, M., Poller, W. C., Kühl, U., Kandolf, R., et al. (2005) · Circulation · doi:10.1161/01.cir.0000155615.68924.b3 · Cited by 258
Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy
Parks, S. B., Kushner, J. D., Nauman, D. J., Burgess, D., Ludwigsen, S., Peterson, A., Li, D., Jakobs, P. M., Litt, M. J., Porter, C., et al. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.01.026 · Cited by 256
Self-citation
Clinical and Demographic Predictors of Outcomes in Recent Onset Dilated Cardiomyopathy
McNamara, D. M., Starling, R. C., Cooper, L. T., BOEHMER, J. P., Mather, P. J., Janosko, K. M., Gorcsan, J., Kip, K. E., & Dec, G. W. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.05.033 · Cited by 243
The Cardiovascular Effects of Cocaine
Havakuk, O., Rezkalla, S. H., & Kloner, R. A. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.014 · Cited by 243
Coding Sequence Rare Variants Identified in MYBPC3 , MYH6 , TPM1 , TNNC1 , and TNNI3 From 312 Patients With Familial or Idiopathic Dilated Cardiomyopathy
Hershberger, R. E., Norton, N., Morales, A., et al. (2010) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.912345 · Cited by 237
Self-citation
Soluble ST2 for Predicting Sudden Cardiac Death in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction
Pascual-Figal, D. A., Ordóñez‐Llanos, J., Tornel, P. L., Vázquez, R., Puig, T., Valdés, M., Juan Cinca, A., Bayés‐Genís, A., & Bayés‐Genís, A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.041 · Cited by 233
Cardiac myosin-Th17 responses promote heart failure in human myocarditis
Myers, J. M., Cooper, L. T., Kem, D. C., Stavrakis, S., Kosanke, S. D., Shevach, E. M., Fairweather, D., Stoner, J. A., Cox, C. J., & Cunningham, M. W. (2016) · JCI Insight · doi:10.1172/jci.insight.85851 · Cited by 230
Self-citation
Enteroviral RNA Replication in the Myocardium of Patients With Left Ventricular Dysfunction and Clinically Suspected Myocarditis
Pauschinger, M., Doerner, A., Kuehl, U., Schwimmbeck, P. L., Poller, W. C., Kandolf, R., & Schultheiß, H. (1999) · Circulation · doi:10.1161/01.cir.99.7.889 · Cited by 223
Cutting Edge: Cross-Regulation by TLR4 and T cell Ig Mucin-3 Determines Sex Differences in Inflammatory Heart Disease
Frisancho-Kiss, S., Davis, S. E., Nyland, J. F., Frisancho, J. A., Cihakova, D., Barrett, M. A., Rose, N. R., & Fairweather, D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6710 · Cited by 212
Self-citation
Effects of gonadectomy and hormonal replacement on rat hearts.
Scheuer, J., Malhotra, A., Schaible, T., & Capasso, J. M. (1987) · Circulation Research · doi:10.1161/01.res.61.1.12 · Cited by 209
Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes
Walsh, R., Buchan, R. J., Wilk, A., John, S., Felkin, L. E., Thomson, K. L., Tang, H. C., Chin, C., Pua, C. J., Raphael, C. E., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw603 · Cited by 205
Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy
Caforio, A. L. P., Bonifacio, E. E., Stewart, J. T., Neglia, D., Parodi, O., Bottazzo, G. F., & McKenna, W. J. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)92821-i · Cited by 201
Self-citation
Identification of Novel Mutations in RBM20 in Patients with Dilated Cardiomyopathy
Li, D., Morales, A., Gonzalez‐Quintana, J., Norton, N., Siegfried, J. D., Hofmeyer, M. R., & Hershberger, R. E. (2010) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2010.00198.x · Cited by 199
Self-citation
Interferon-γ Protects against Chronic Viral Myocarditis by Reducing Mast Cell Degranulation, Fibrosis, and the Profibrotic Cytokines Transforming Growth Factor-β1, Interleukin-1β, and Interleukin-4 in the Heart
Fairweather, D., Frisancho-Kiss, S., Yusung, S. A., Barrett, M. A., Davis, S. E., Gatewood, S. J. L., Njoku, D. B., & Rose, N. R. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63241-5 · Cited by 198
Self-citation
Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis
Lauer, B., Schannwell, M., Kühl, U., Strauer, B.-E., & Schultheiss, H.-P. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00485-4 · Cited by 197
Autoantibodies in Heart Failure and Cardiac Dysfunction
Kaya, Z., Leib, C., & Katus, H. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.243360 · Cited by 194
Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target
Glezeva, N., & Baugh, J. A. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9405-8 · Cited by 194
Mutations in Troponin that cause HCM, DCM AND RCM: What can we learn about thin filament function?
Willott, R. H., Gomes, A. V., Chang, A. N., Parvatiyar, M. S., Pinto, J. R., & Potter, J. D. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.10.031 · Cited by 193
Cardiovascular effects of androgenic-anabolic steroids
Melchert, R. B., & Welder, A. A. (1995) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199509000-00004 · Cited by 187
Transforming growth factor-β-dependent Wnt secretion controls myofibroblast formation and myocardial fibrosis progression in experimental autoimmune myocarditis
Błyszczuk, P., Müller‐Edenborn, B., Valenta, T., Osto, E., Stellato, M., Behnke, S., Glatz, K., Basler, K., Lüscher, T. F., Distler, O., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw116 · Cited by 186
Myeloid Differentiation Factor-88 Plays a Crucial Role in the Pathogenesis of Coxsackievirus B3–Induced Myocarditis and Influences Type I Interferon Production
Fuse, K., Chan, G. C., Liu, Y., Gudgeon, P., Husain, M., Chen, M., Yeh, W., Akira, S., & Liu, P. P. (2005) · Circulation · doi:10.1161/circulationaha.105.536433 · Cited by 180
Self-citation
Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
Saxon, L. A., Stevenson, W. G., Middlekauff, H. R., Fonarow, G. C., Woo, M. A., Moser, D. K., & Stevenson, L. W. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90220-7 · Cited by 180
Role of titin in cardiomyopathy: from DNA variants to patient stratification
Ware, J. S., & Cook, S. A. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.190 · Cited by 176
Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy
Murphy, R. T., Mogensen, J., Shaw, A., Kubo, T., Hughes, S., & McKenna, W. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15468-8 · Cited by 176
The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease
Liu, P. J., AITKEN, K. J., Kong, Y., Opavsky, M. A., Martino, T. A., Dawood, F., Wen, W.-H., Kozieradzki, I., Bachmaier, K., Straus, D. B., et al. (2000) · Nature Medicine · doi:10.1038/74689 · Cited by 174
Self-citation
Gender Related Differences in Patients Presenting with Acute Heart Failure. Results from EuroHeart Failure Survey II
Nieminen, M. S., Harjola, V., Hochadel, M., Drexler, H., Michel Komajda, N., Brutsaert, D. L., Dickstein, K., Ponikowski, P. P., Tavazzi, L., Folláth, F., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.12.012 · Cited by 170
A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy
Meder, B., Rühle, F., Weis, T., Homuth, G., Keller, A., Franke, J., Peil, B., Bermejo, J. L., Frese, K., Huge, A., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht251 · Cited by 169
Self-citation
Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene
Villard, E., Duboscq-Bidot, L., Charron, P., Benaiche, A., Conraads, V. M., Sylvius, N. B., & Michel Komajda, N. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi193 · Cited by 167
Echocardiographic assessment of left ventricular systolic function
Klæboe, L. G., & Edvardsen, T. (2018) · Journal of Echocardiography · doi:10.1007/s12574-018-0405-5 · Cited by 167
Evidence from family studies for autoimmunity in dilated cardiomyopathy
Caforio, A. L. P., Keeling, P. J., McKenna, W. J., Mann, J., Caforio, A. L. P., Bottazzo, G. F., Zachara, E., Mestroni, L., & Camerini, F. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92339-6 · Cited by 165
Self-citation
The effect of nurse-led education on hospitalisation, readmission, quality of life and cost in adults with heart failure. A systematic review
Rice, H. T., Say, R., & Betihavas, V. (2017) · Patient Education and Counseling · doi:10.1016/j.pec.2017.10.002 · Cited by 164
Rat dilated cardiomyopathy after autoimmune giant cell myocarditis.
Kodama, M., Hanawa, H., Saeki, M., Hosono, H., Inomata, T., Suzuki, K., & Shibata, A. (1994) · Circulation Research · doi:10.1161/01.res.75.2.278 · Cited by 164
Mimicry and Antibody-Mediated Cell Signaling in Autoimmune Myocarditis
Li, Y., Heuser, J. S., Cunningham, L. C., Kosanke, S. D., & Cunningham, M. W. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.8234 · Cited by 155
Echocardiographic Assessment of Left Ventricular Systolic Function: An Overview of Contemporary Techniques, Including Speckle-Tracking Echocardiography
Luis, S. A., Chan, J. H., & Pellikka, P. A. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.07.017 · Cited by 154
Cardiomyopathies: An Overview
Braunwald, E. (2017) · Circulation Research · doi:10.1161/circresaha.117.311812 · Cited by 150
Interferon-Beta Improves Survival in Enterovirus-Associated Cardiomyopathy
Kühl, U., Laßner, D., von Schlippenbach, J., Poller, W. C., & Schultheiß, H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.026 · Cited by 150
Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy
Caforio, A. L. P., Tona, F., Bottaro, S., Vinci, A., Dequal, G., Daliento, L., Thiene, G., & Iliceto, S. (2008) · Autoimmunity · doi:10.1080/08916930701619235 · Cited by 148
Self-citation
Sex- and Age-Based Differences in the Natural History and Outcome of Dilated Cardiomyopathy
Halliday, B. P., Gulati, A., Ali, A., Newsome, S., Lota, A. S., Tayal, U., Vassiliou, V. S., Aržanauskaitė, M., İzgi, C., Krishnathasan, K., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1216 · Cited by 148
Cardiotoxicity After Childhood Cancer: Beginning With the End in Mind
Lipshultz, S. E., & Adams, M. J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.5751 · Cited by 146
Self-citation
Circulating blood cells and extracellular vesicles in acute cardioprotection
Davidson, S. M., Andreadou, I., Barile, L., Birnbaum, Y., Cabrera-Fuentes, H. A., Cohen, M. V., Downey, J. M., Girão, H., Pagliaro, P., Penna, C. R. R., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy314 · Cited by 145
Gonadectomy of male BALB/c mice increases Tim-3+ alternatively activated M2 macrophages, Tim-3+ T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis
Frisancho-Kiss, S., Coronado, M. J., Frisancho, J. A., Lau, V. M., Rose, N. R., Klein, S. L., & Fairweather, D. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.12.002 · Cited by 143
Self-citation
Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy
Schultheiß, H., Piper, C., Sowade, O., Waagstein, F., Kapp, J. F., Wegscheider, K., Groetzbach, G., Pauschinger, M., Escher, F., Arbustini, E., et al. (2016) · Clinical Research in Cardiology · doi:10.1007/s00392-016-0986-9 · Cited by 143
Self-citation
Use of Nonclonal Serum Immunoglobulin Free Light Chains to Predict Overall Survival in the General Population
Dispenzieri, A. A., Katzmann, J. A., Kyle, R. A., Larson, D. R., Therneau, T. M., Colby, C. L., Clark, R. J., Mead, G. P., Kumar, S. K., Melton, L. J., et al. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.03.009 · Cited by 138
Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo.
Schulze, K. J., Becker, B. F., & Schultheiß, H. (1989) · Circulation Research · doi:10.1161/01.res.64.2.179 · Cited by 137
Dilated cardiomyopathy-associatedBAG3mutations impair Z-disc assembly and enhance sensitivity to apoptosis in cardiomyocytes
Arimura, T., Ishikawa, T., Nunoda, S., Kawai, S., & Kimura, A. (2011) · Human Mutation · doi:10.1002/humu.21603 · Cited by 134
Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure
Villacorta, H., & Maisel, A. S. (2015) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20150151 · Cited by 130
Mechanisms of toxic cardiomyopathy
Hantson, P. (2018) · Clinical Toxicology · doi:10.1080/15563650.2018.1497172 · Cited by 129
FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy
Begay, R. L., Tharp, C. A., Martin, A., Graw, S. L., Sinagra, G., Miani, D., Sweet, M., Slavov, D. B., Stafford, N., Zeller, M. J., et al. (2016) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2016.05.004 · Cited by 126
Myocarditis and Heart Failure Associated With Hepatitis C Virus Infection
Matsumori, A., Shimada, T., Chapman, N. M., Tracy, S., & Mason, J. W. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.11.004 · Cited by 122
Self-citation
Pediatric Cardiomyopathies: causes, epidemiology, Clinical course, Preventive Strategies and Therapies
Lipshultz, S. E., Cochran, T. R., Briston, D. A., Brown, S. R., Sambatakos, P., Miller, T. L., Carrillo, A. A., Corcia, L., Sanchez, J. E., Diamond, M. B., et al. (2013) · Future Cardiology · doi:10.2217/fca.13.66 · Cited by 117
Self-citation
Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n
Coronado, M. J., Brandt, J. E., Kim, E., Bucek, A., Bedja, D., Abston, E. D., Shin, J., Gabrielson, K. L., Mitzner, W., & Fairweather, D. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00783.2011 · Cited by 116
Self-citation
Mast Cells and Innate Cytokines are Associated with Susceptibility to Autoimmune Heart Disease Following Coxsackievirus B3 Infection
Fairweather, D., Frisancho-Kiss, S., Gatewood, S., Njoku, D., Steele, R., Barrett, M., & Rose, N. R. (2004) · Autoimmunity · doi:10.1080/0891693042000196200 · Cited by 115
Self-citation
Age and gender effects on the extent of myocardial involvement in acute myocarditis: a cardiovascular magnetic resonance study
Cocker, M. S., Abdel-Aty, H., Strohm, O., & Friedrich, M. G. (2009) · Heart · doi:10.1136/hrt.2008.164061 · Cited by 115
Exome Sequencing and Genome-Wide Linkage Analysis in 17 Families Illustrate the Complex Contribution of TTN Truncating Variants to Dilated Cardiomyopathy
Norton, N., Li, D., Rampersaud, E., Morales, A., Martin, E. R., Zuchner, S. L., Guo, S., Gonzalez, M., Hedges, D. J., Robertson, P. D., et al. (2013) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.111.000062 · Cited by 115
Self-citation
Prognostic Relevance of Gene-Environment Interactions in Patients With Dilated Cardiomyopathy
Hazebroek, M. R., Moors, S., Dennert, R. M., van den Wijngaard, A., Krapels, I. P. C., Hoos, M. B., Verdonschot, J. A. J., Merken, J. J., de Vries, B., Wolffs, P. F. G., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.023 · Cited by 115
Early and Sustained Benefit on Event-Free Survival and Heart Failure Hospitalization From Fixed-Dose Combination of Isosorbide Dinitrate/Hydralazine: Consistency Across Subgroups in the African-American Heart Failure Trial
Taylor, A. L., Ziesche, S., Yancy, C. W., Carson, P., Ferdinand, K., Taylor, M., Adams, K., Olukotun, A. Y., Ofili, E., Tam, S. W., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.644013 · Cited by 114
Clinical and Functional Characterization of TNNT2 Mutations Identified in Patients With Dilated Cardiomyopathy
Hershberger, R. E., Pinto, J. R., Parks, S. B., Kushner, J. D., Li, D., Ludwigsen, S., Cowan, J. R., Morales, A., Parvatiyar, M. S., & Potter, J. D. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.108.846733 · Cited by 107
Self-citation
Cardiac Phenotypes in Hereditary Muscle Disorders
Arbustini, E., Toro, A. D., Giuliani, L., Favalli, V., Narula, N., & Grasso, M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.2182 · Cited by 105
Hemodynamic improvement and removal of autoantibodies against β1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy
Mobini, R., Staudt, A., Felix, S. B., et al. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00042-8 · Cited by 105
Expression of Functional T-Cell Markers and T-Cell Receptor Vbeta Repertoire in Endomyocardial Biopsies from Patients Presenting with Acute Myocarditis and Dilated Cardiomyopathy
Noutsias, M., Rohde, M., Göldner, K., Block, A., Blunert, K., Hemaidan, L., Hummel, M., Blohm, J.-H., Laßner, D., Kühl, U., et al. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr014 · Cited by 103
BAG3: a new player in the heart failure paradigm
Knezevic, T., Myers, V. D., Gordon, J., Tilley, D. G., Sharp, T. E., Wang, J., Khalili, K., Cheung, J. Y., & Feldman, A. M. (2015) · Heart Failure Reviews · doi:10.1007/s10741-015-9487-6 · Cited by 101
Eosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy
Diny, N. L., Baldeviano, G. C., Talor, M. V., Barin, J. G., Ong, S., Bedja, D., Hays, A. G., Gilotra, N. A., Coppens, I., Rose, N. R., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161702 · Cited by 99
Elevated Sera sST2 Is Associated With Heart Failure in Men ≤50 Years Old With Myocarditis
Coronado, M. J., Bruno, K. A., Blauwet, L. A., Tschöpe, C., Cunningham, M. W., Pankuweit, S., van Linthout, S., Jeon, E., McNamara, D. M., Krejčí, J., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.008968 · Cited by 99
Self-citation
Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy
Escher, F., Kühl, U., Laßner, D., Poller, W. C., Westermann, D., Pieske, B. M., Tschöpe, C., & Schultheiß, H. (2016) · Clinical Research in Cardiology · doi:10.1007/s00392-016-1011-z · Cited by 99
Self-citation
Symptomatic cardiac involvement in juvenile rheumatoid arthritis
Goldenberg, J., Ferraz, M. B., Pessoa, A. P., da Fonseca, A. S., Carvalho, A. C., Hilário, M. O. E., & Atra, E. (1992) · International Journal of Cardiology · doi:10.1016/0167-5273(92)90082-e · Cited by 95
Phospholamban R14 Deletion Results in Late-Onset, Mild, Hereditary Dilated Cardiomyopathy
DeWitt, M. M., MacLeod, H. M., Soliven, B. C., & McNally, E. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.016 · Cited by 92
Identification and Functional Characterization of Cardiac Troponin I As a Novel Disease Gene in Autosomal Dominant Dilated Cardiomyopathy
Carballo, S., Robinson, P. J., Otway, R., Fatkin, D., Jongbloed, J. D. H., de Jonge, N., Blair, E. M., van Tintelen, J. P., Redwood, C. S., & Watkins, H. C. (2009) · Circulation Research · doi:10.1161/circresaha.109.196055 · Cited by 90
Adverse Cardiac Effects of Acute Alcohol Ingestion in Young Adults
Lang, R. M., BOROW, K. M., NEUMANN, A., & Feldman, T. E. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-6-742 · Cited by 89
Comparison of 18F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis
Ohira, H., Birnie, D. H., Peña, E., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3181-8 · Cited by 89
NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis
Tschöpe, C., Müller, I., Xia, Y., Savvatis, K., Pappritz, K., Pinkert, S., Lassner, D., Heimesaat, M. M., Spillmann, F., Miteva, K., et al. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.117.003870 · Cited by 88
Self-citation
Where Genome Meets Phenome: Rationale for Integrating Genetic and Protein Biomarkers in the Diagnosis and Management of Dilated Cardiomyopathy and Heart Failure
Piran, S., Liu, P. X., Morales, A., & Hershberger, R. E. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.05.005 · Cited by 87
Self-citation
A Novel Fluorescence Method for the Rapid Detection of Functional β1-Adrenergic Receptor Autoantibodies in Heart Failure
Nikolaev, V. O., Boivin, V., Störk, S., Angermann, C. E., Ertl, G., Lohse, M. J., & Jahns, R. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.051 · Cited by 87
A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia
Liu, G., Morales, A., Vafiadaki, E., Lam, C. K., Cai, W., Haghighi, K., Adly, G., Hershberger, R. E., & Kranias, E. G. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv127 · Cited by 85
Self-citation
Complement Receptor 1 and 2 Deficiency Increases Coxsackievirus B3-Induced Myocarditis, Dilated Cardiomyopathy, and Heart Failure by Increasing Macrophages, IL-1β, and Immune Complex Deposition in the Heart
Fairweather, D., Frisancho-Kiss, S., Njoku, D. B., Nyland, J. F., Kaya, Z., Yusung, S. A., Davis, S. E., Frisancho, J. A., Barrett, M. A., & Rose, N. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3516 · Cited by 82
Self-citation
Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy
Mahon, N., Madden, B. P., Caforio, A. L. P., Elliot, P. M., Haven, A. J., Keogh, B. E., Davies, M. J., & McKenna, W. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01762-4 · Cited by 82
Self-citation
Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAβ knockout NOD mice
Elliott, J. F., Liu, J., Yuan, Z.-N., Bautista-Lopez, N., Wallbank, S. L., Suzuki, K., Rayner, D., Nation, P., Robertson, M. A., Liu, G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235552100 · Cited by 80
MHC class II genes influence the susceptibility to chronic active hepatitis C
Höhler, T., Gerken, G., Notghi, A., Knolle, P. A., Lubjuhn, R., Taheri, H., Schneider, P. M., Büschenfelde, K. H. M. Z., & Rittner, C. K. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80169-9 · Cited by 79
Identification of a novel frameshift mutation in the giant muscle filament titin in a large Australian family with dilated cardiomyopathy
Gerull, B., Atherton, J. J., Geupel, A., Klaassen, S., Heuser, A., Frenneaux, M. P., McNabb, M., Granzier, H., Labeit, S., & Thierfelder, L. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0060-6 · Cited by 75
Frequency of coronary artery disease and left ventricular dysfunction in cocaine users
Om, A., Warner, M., Sabri, N., et al. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90701-y · Cited by 72
Improved diagnosis of idiopathic giant cell myocarditis and cardiac sarcoidosis by myocardial gene expression profiling
Lassner, D., Kuhl, U., Siegismund, C. S., Rohde, M., Elezkurtaj, S., Escher, F., Tschope, C., Gross, U. M., Poller, W., & Schultheiss, H. P. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu101 · Cited by 71
Self-citation
Progress and Challenge of Cardiac Regeneration to Treat Heart Failure
Isomi, M., Sadahiro, T., & Ieda, M. (2018) · Journal of Cardiology · doi:10.1016/j.jjcc.2018.10.002 · Cited by 69
A Systematic Analysis of Genetic Dilated Cardiomyopathy Reveals Numerous Ubiquitously Expressed and Muscle-Specific Genes
Harakaľová, M., Kummeling, G. J. M., Sammani, A., Linschoten, M., Baas, A. F., van der Smagt, J. J., Doevendans, P. A., van Tintelen, J. P., Dooijes, D., Mokrý, M., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.255 · Cited by 68
A comparative analysis of novel cardiovascular biomarkers in patients with chronic heart failure
Lichtenauer, M., Jirak, P., Wernly, B., et al. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.05.027 · Cited by 66
Improving Survival Rates of Patients With Idiopathic Dilated Cardiomyopathy in Tuscany Over 3 Decades
Castelli, G., Fornaro, A., Ciaccheri, M., Dolara, A., Troiani, V., Tomberli, B., Olivotto, I., & Gensini, G. F. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.000120 · Cited by 65
Cardiac complications of cocaine abuse
Chakko, S. C., & Myerburg, R. J. (1995) · Clinical Cardiology · doi:10.1002/clc.4960180206 · Cited by 65
Modern Imaging Techniques in Cardiomyopathies
Jan, M. F., & Tajik, A. J. (2017) · Circulation Research · doi:10.1161/circresaha.117.309600 · Cited by 64
Recovery of normal ventricular function in patients with dilated cardiomyopathy: Predictors of an increasingly prevalent clinical event
Binkley, P. F., Lesinski, A., Ferguson, J. P., Hatton, P. S., Yamokoski, L. M., Hardikar, S. S., Cooke, G. E., & Leier, C. V. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.08.010 · Cited by 63
The Incremental Prognostic and Clinical Value of Multiple Novel Biomarkers in Heart Failure
Jackson, C. E., Haig, C. E., Welsh, P. I., Dalzell, J. R., Tsorlalis, I. K., McConnachie, A., Preiss, D., Anker, S. D., Sattar, N. A., Petrie, M. C., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.543 · Cited by 63
Self-citation
Functional Characterization of TNNC1 Rare Variants Identified in Dilated Cardiomyopathy
Pinto, J. R., Siegfried, J. D., Parvatiyar, M. S., Li, D., Norton, N., Jones, M., Liang, J., Potter, J. D., & Hershberger, R. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.267211 · Cited by 61
Self-citation
Peripartum cardiomyopathy-diagnosis, management, and long term implications
Stergiopoulos, K., & Lima, F. V. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.07.012 · Cited by 57
Myocardial Expression of Fas and Recovery of Left Ventricular Function in Patients With Recent-Onset Cardiomyopathy
Sheppard, R. J., Bedi, M., Kubota, T., Semigran, M. J., Dec, G. W., Holubkov, R., Feldman, A. M., Rosenblum, W. D., McTiernan, C. F., & McNamara, D. M. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.067 · Cited by 56
Toward Genetics-Driven Early Intervention in Dilated Cardiomyopathy
Kinnamon, D. D., Morales, A., Bowen, D. J., Burke, W., Hershberger, R. E., Hershberger, R. E., Kinnamon, D. D., Morales, A., Gastier, J. M., Burke, W., et al. (2017) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.117.001826 · Cited by 54
Self-citation
Passive transfer of affinity-purified anti-heart autoantibodies (AHA) from sera of patients with myocarditis induces experimental myocarditis in mice
Caforio, A. L. P., Angelini, A., Blank, M., Shani, A., Kivity, S., Goddard, G., Doria, A., Schiavo, A., Testolina, M., Bottaro, S., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.10.165 · Cited by 53
Self-citation
Cardiac inflammation in genetic dilated cardiomyopathy caused by MYBPC3 mutation
Lynch, T. L., Ismahil, M. A., Jegga, A. G., Zilliox, M. J., Troidl, C., Prabhu, S. D., & Sadayappan, S. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.12.002 · Cited by 53
Differences in Presentation and Outcomes Between Children With Familial Dilated Cardiomyopathy and Children With Idiopathic Dilated Cardiomyopathy
Rusconi, P. G., Wilkinson, J. D., Sleeper, L. A., et al. (2017) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002637 · Cited by 52
Molecular epidemiology of enterovirus and parechovirus infections according to patient age over a 4‐year period in Spain
Cabrerizo, M., de Cerio, M. D., Muñoz‐Almagro, C., Rabella, N., Tarragó, D., Romero‐Gómez, M. P., Pena, M. J., Calvo, C., Rey‐Cao, S., Moreno‐Docón, A., et al. (2016) · Journal of Medical Virology · doi:10.1002/jmv.24658 · Cited by 51
Multimodality imaging approach in the diagnosis of chronic myocarditis with preserved left ventricular ejection fraction (MCpEF): The role of 2D speckle-tracking echocardiography
Kašner, M., Aleksandrov, A., Escher, F., Al‐Saadi, N., Makowski, M. R., Spillmann, F., Genger, M., Schultheiß, H., Kühl, U., Pieske, B. M., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.05.038 · Cited by 51
Self-citation
Free light chains: Eclectic multipurpose biomarker
Basile, U., Gulli, F., Gragnani, L., Napodano, C., Pocino, K., Rapaccini, G. L., Mussap, M., & Zignego, A. L. (2017) · Journal of Immunological Methods · doi:10.1016/j.jim.2017.09.005 · Cited by 48

Research works printed but not linked: 20

Maron, B. J. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113, 1807–1816 (2006). · DOI
Maron, B. J. et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary artery risk development in (young) adults. Circulation 92, 785–789 (1995). · DOI
Alvarez, J. A. et al. Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the Pediatric Cardiomyopathy Registry. Circulation 124, 814–823 (2011). · DOI
Hershberger, R. E. & Morales, A. Dilated cardiomyopathy overview. GeneReviews https://www.ncbi.nlm.nih.gov/books/NBK1309 (updated 23 Aug 2018).
Li, A.-H., Liu, P. P., Villarreal, F. J. & Garcia, R. A. Dynamic changes in myocardial matrix and relevance to disease: translational perspectives. Circ. Res. 114, 916–927 (2014). · DOI
Maekawa, Y., Ouzounian, M., Opavsky, M. A. & Liu, P. P. Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity. Circulation 115, 5–8 (2006). · DOI
Caforio, A. L. P. et al. Prospective familial assessment in dilated cardiomyopathy: cardiac autoantibodies predict disease development in asymptomatic relatives. Circulation 115, 76–83 (2006). · DOI
Mestroni, L. et al. Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. J. Am. Coll. Cardiol. 34, 181–190 (1999). · DOI
Bellinger, A. M. et al. Cardio-oncology: how new targeted cancer therapies and precision medicine can inform cardiovascular discovery. Circulation 132, 2248–2258 (2015). · DOI
Abston, E. D. et al. IL-33 independently induces eosinophilic pericarditis and cardiac dilation: ST2 improves cardiac function. Circ. Heart Fail. 5, 366–375 (2012). · DOI · Paper page
Chimenti, C. & Frustaci, A. Contribution and risks of left ventricular endomyocardial biopsy in patients with cardiomyopathies: a retrospective study over a 28-year period. Circulation 128, 1531–1541 (2013). · DOI
Holzmann, M. et al. Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. Circulation 118, 1722–1728 (2008). · DOI
Packer, M. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 106, 2194–2199 (2002). · DOI · Paper page
Golwala, H., Bajaj, N. S., Arora, G. & Arora, P. Implantable cardioverter-defibrillator for nonischemic cardiomyopathy: an updated meta-analysis. Circulation 135, 201–203 (2017). · DOI
Matsuo, S., Nakajima, K. & Nakata, T. Prognostic value of cardiac sympathetic nerve imaging using long-term follow-up data. Circulation 80, 435–441 (2016). · DOI
Minton, E. J. et al. Association between MHC class II alleles and clearance of circulating hepatitis C virus. Members of the Trent Hepatitis C Virus Study Group. J. Infect. Dis 178, 39–44 (1998). · DOI
Matsumori, A. et al. in Cardiomyopathies and Heart Failure: Biomolecular, Infectious, and Immune Mechanisms (Kluwer Academic Publishers, 2003). · DOI
Shichi, D. et al. The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III - class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy. Tissue Antigens 66, 200–208 (2005). · DOI
Sen-Chowdhry, S. et al. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J. Am. Coll. Cardiol. 52, 2175–2187 (2008). · DOI
Lakdawala, N. K. et al. Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy. J. Am. Coll. Cardiol. 55, 320–329 (2010). · DOI

Sorted by citations

Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Sex differences in inflammation, redox biology, mitochondria and autoimmunity
Di Florio, D. N., Sin, J., Coronado, M. J., Atwal, P. S., & Fairweather, D. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101482 · Cited by 185
Self-citation
COVID-19, Myocarditis and Pericarditis
Fairweather, D., Beetler, D. J., Di Florio, D. N., Musigk, N., Heidecker, B., & Cooper, L. T. (2023) · Circulation Research · doi:10.1161/circresaha.123.321878 · Cited by 194
Self-citation
Sex and gender differences in myocarditis and dilated cardiomyopathy: An update
Fairweather, D., Beetler, D. J., Musigk, N., Heidecker, B., Lyle, M. A., Cooper, L. T., & Bruno, K. A. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1129348 · Cited by 124
Self-citation

See all 720

Authors: Schultheiss, H.-P., Fairweather, D., Caforio, A. L. P., Escher, F., Hershberger, R. E., Lipshultz, S. E., Liu, P. P., Matsumori, A., Mazzanti, A., McMurray, J., & Priori, S. G.
Affiliations: Institut Kardiale Diagnostik und Therapie (DE)
Mayo Clinic (US)
University of Padua (IT)
German Centre for Cardiovascular Research (DE)
The Ohio State University (US)
Roswell Park Comprehensive Cancer Center (US)
University of Ottawa (CA)
Kyoto Medical Center (JP)
University of Pavia (IT)
British Heart Foundation (GB)
Corresponding author: Schultheiss, Heinz-Peter
Fairweather, DeLisa
ORCID: Schultheiss, Heinz-Peter
Fairweather, DeLisa
Caforio, Alida L. P.
Escher, Felicitas
Hershberger, Ray E.
Lipshultz, Steven E.
Liu, Peter P.
Matsumori, Akira
Mazzanti, Andrea
McMurray, John
Priori, Silvia G.
Venue: Nature Reviews Disease Primers
Publisher: Springer Science and Business Media LLC
Published: 2019-05-09
Volume: 5
Issue: 1
Pages: 32-32
ISSN: 2056-676X (ISSN-L)
DOI: 10.1038/s41572-019-0084-1
PMC: PMC7096917
OpenAlex: W4211051044
Cited by: 720
References: 235
Citations by year: 2026: 81 · 2025: 117 · 2024: 141 · 2023: 135 · 2022: 107 · 2021: 86 · 2020: 45 · 2019: 7
FWCI: 11.10
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Disease Primers (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Research Bank (Australian Catholic University) (submittedVersion)
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion, cc-by-sa)
Padua Research Archive (University of Padova) (submittedVersion)
Funders: American Heart Association (16GRNT30950007)
Deutsche Forschungsgemeinschaft
European Research Area Network on Cardiovascular Diseases (JTC2016-40-158)
National Institutes of Health (NIH-R01)
National Heart, Lung, and Blood Institute (R01HL111938)
National Institute of Allergy and Infectious Diseases (R21AI145356)
National Institute of Environmental Health Sciences (R21ES024414)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Keywords: dilated cardiomyopathy, left ventricular dilatation, sarcomere gene mutations, viral myocarditis, drug-induced cardiomyopathy, autoimmune cardiomyopathy, endomyocardial biopsy, echocardiography, myocardial remodelling, heart failure, cardiac resynchronization therapy, implantable cardioverter-defibrillator, cardiac arrhythmias, serum biomarkers, personalized treatment
MeSH terms: Cardiomyopathy, Dilated, Echocardiography, Electrocardiography, Heart Failure, Humans, Inflammation, Magnetic Resonance Imaging, Prognosis, Quality of Life, Sex Factors, Autoimmunity, Cardiac Resynchronization Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Dilated cardiomyopathy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks